Lam Research Corporation
NASDAQ:LRCXSemiconductors
+$19.70 today
- Market cap
- $264.41B
- Beta
- 1.87
- P/E (TTM)
- 73.4
- EPS (TTM)
- $5.37
- Dividend yield
- 0.26%
Volume 7.61M
Average 11.84M
LRCX Common Stock Issued
Cash raised by issuing new shares.
Lam Research CorporationNASDAQ: LRCX
Common Stock Issued · Q1 FY2027 · quarter ended Sep 2026
Common stock issued outflow grows to $4.26M
Q1 FY2027 common stock issued was $4.26M, compared with $0 a year earlier. Trailing-twelve-month common stock issued was $110.49M. Over 3 fiscal years it compounded at +16.2% a year.
Context
- Common stock issued amounted to 0.1% of revenue in FY2026, down 0.7 pp from a year earlier.
- Common stock issued increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly common stock issued holds near $4.26M or moves back toward the trailing-twelve-month quarterly average of $27.62M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2026
- 17.45M USD
- Year-over-year change
- -87.8%
- 4-year CAGR
- +32.4%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-28 | 17.45M | -87.8% |
| FY2025 | 2025-06-29 | 142.57M | +816.6% |
| FY2024 | 2024-06-30 | 15.55M | +40.0% |
| FY2023 | 2023-06-25 | 11.11M | +95.5% |
| FY2022 | 2022-06-26 | 5.68M | — |
Common Stock Issued vs competitors
How LRCX compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock issued is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -22.5% is the 3rd highest of 6, against a peer median of -25.4%.
- Common stock issued amounts to 0.4% of revenue for LRCX, versus a peer median of 0.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $775.17M USD | +2644.5% | +694.0% | 74.7% | |
| LTM Oct 2026 | $266M USD | +1.9% | +5.4% | 0.8% | |
| LTM Jun 2026 | $113.03M USD | -25.4% | +10.5% | 0.8% | |
| LTM Sep 2026 | $110.49M USD | -22.5% | +16.2% | 0.4% | |
| LTM Sep 2026 | €67.7M EUR | -52.2% | +20.3% | 0.2% | |
| LTM Sep 2026 | $909K USD | -80.8% | +8.5% | 0.1% | |
| Peer median (excluding LRCX) | — | -25.4% | +10.5% | 0.8% | |
Competitors are the stored peer set for LRCX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Net Income | 4.61B | 4.51B | 3.83B | 5.36B | 7.27B |
| Depreciation & Amortization | 333.74M | 342.43M | 359.7M | 386.28M | 441.53M |
| Deferred Income Tax | (257.44M) | (172.06M) | (198.98M) | (363.25M) | (289.06M) |
| Stock-Based Compensation | 259.06M | 286.6M | 293.06M | 343.37M | 386.38M |
| Change in Working Capital | (1.8B) | 158.74M | 360.48M | 441.8M | (1.91B) |
| Accounts Receivables | (1.29B) | 1.45B | 303.44M | (858.75M) | 0 |
| Inventory | (1.35B) | (961.97M) | 528.72M | (180.73M) | 0 |
| Accounts Payables | 167.88M | (522.2M) | 125.94M | 212M | 0 |
| Other Working Capital | 674.91M | 190.65M | (597.63M) | 1.27B | (1.91B) |
| Other Non-Cash Items | (44.75M) | 52.3M | 10.24M | 6.85M | (32.71M) |
| Operating Cash Flow | 3.1B | 5.18B | 4.65B | 6.17B | 5.86B |
| Capital Expenditures | (546.03M) | (501.57M) | (396.67M) | (759.19M) | (966.41M) |
| Acquisitions (Net) | 0 | (119.96M) | 0 | 0 | 0 |
| Purchases of Investments | (567.82M) | (98.13M) | 0 | 0 | 0 |
| Sales of Investments | 1.73B | 98.13M | 37.77M | 0 | 0 |
| Other Investing Activities | (7.58M) | 86.96M | (11.71M) | 51.09M | 44.25M |
| Investing Cash Flow | 612.28M | (534.56M) | (370.61M) | (708.09M) | (922.15M) |
| Debt Repayment | (11.89M) | (23.21M) | (256.1M) | (507.49M) | (755.43M) |
| Common Stock Issued | 5.68M | 11.11M | 15.55M | 142.57M | 17.45M |
| Common Stock Repurchased | (3.87B) | (2.02B) | (2.84B) | (3.42B) | (3.85B) |
| Dividends Paid | (815.29M) | (907.91M) | (1.02B) | (1.15B) | (1.27B) |
| Other Financing Activities | 108.22M | 106.35M | 106.42M | 143K | 142.17M |
| Financing Cash Flow | (4.58B) | (2.83B) | (4B) | (4.94B) | (5.72B) |
| Effect of Forex Changes | (30.23M) | 128K | (22.37M) | 28.32M | (27.43M) |
| Net Change in Cash | (897.22M) | 1.81B | 263.43M | 556.85M | (809.71M) |
| Free Cash Flow | 2.55B | 4.68B | 4.26B | 5.41B | 4.89B |
Lam Research Corporation
NASDAQ:LRCX
Intrinsic Alpha fair value
Locked
Current Price
$211.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.